Drug Expiration Date Testing Lengthening and Transparency

Year: 2011

Resolution Number: 47

Action Taken: Approved as Amended

Status:

Author(s): Samuel W. Terman, Angeline Wang, Amrit Misra, and Ami Badami, MD

Sponsor: Samuel W. Terman

On behalf of: Medical Student Section

Committee: D (Public Health)

Resolved Section(s):
RESOLVED: That MSMS incorporate AMA’s support for more rigorous, scientifically based stability testing for prescription drugs into its policies; and be it furtherRESOLVED: That the Michigan Delegation to the AMA ask the AMA to encourage the U.S. Food and Drug Administration and the federal government to more rigorously define and make transparent the process of scientifically based stability testing used to determine prescription drug expiration dates.RATIONALE: There was a great deal of discussion during the period of testimony and during deliberations of the committee members on this issue. The Committee is recommending striking the last resolved. It was brought to light by the AMA Advisors that this issue was recently discussed at an AMA meeting. The FDA testified that in the public setting the program that was created by the military for storing and extending the life of drugs could not be duplicated. Medical students again worked on this resolution and should be commended for their hard work.

Fiscal Note: NULL

Resolution: View PDF for Drug Expiration Date Testing Lengthening and Transparency